AngioDynamics, Inc. Stock price

Equities

ANGO

US03475V1017

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
5.39 USD +0.37% Intraday chart for AngioDynamics, Inc. -1.46% -31.25%
Sales 2024 * 312M Sales 2025 * 316M Capitalization 215M
Net income 2024 * -6M Net income 2025 * -40M EV / Sales 2024 * 0.69 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.68 x
P/E ratio 2024 *
-35.9 x
P/E ratio 2025 *
-5.34 x
Employees 815
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.93%
More Fundamentals * Assessed data
Dynamic Chart
AngioDynamics Sells Two Product Lines to Spectrum Vascular for up to $45 Million Cash; Shares Up in Pre-Bell Trading MT
Spectrum Vascular acquired PICC and Midline Product Portfolios from AngioDynamics, Inc. for $45 million. CI
Angiodynamics, Inc. Announces Board Changes CI
AngioDynamics Receives FDA Clearance for Auryon XL Radial Access Catheter MT
Angiodynamics Announces FDA 510(K) Clearance of Auryon Xl Radial Access Catheter to Treat Peripheral Arterial Disease CI
AngioDynamics, Inc. Announces Dennis Meteny to Retire as A Member of the Board of Directors, Member of the Compensation Committee and Chair of the Audit Committee, Effective January 31, 2024 CI
Transcript : AngioDynamics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM
Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating MT
Sector Update: Health Care Stocks Retreat Late Afternoon MT
AngioDynamics Shares Fall After Q2 Swing to Adjusted Loss; Revenue Drops MT
Top MIdday Decliners MT
Transcript : AngioDynamics, Inc., Q2 2024 Earnings Call, Jan 05, 2024
AngioDynamics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023 CI
David D. Helsel to Leave AngioDynamics, Inc. as Senior Vice President of Global Operations and R&D, Effective January 12, 2024 CI
More news
1 day+0.37%
1 week-1.46%
Current month-1.82%
1 month-12.92%
3 months-28.04%
6 months-24.51%
Current year-31.25%
More quotes
1 week
5.27
Extreme 5.27
5.63
1 month
5.27
Extreme 5.265
6.20
Current year
5.27
Extreme 5.265
8.25
1 year
5.27
Extreme 5.265
12.62
3 years
5.27
Extreme 5.265
32.00
5 years
5.27
Extreme 5.265
32.00
10 years
5.27
Extreme 5.265
32.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 16-03-31
Director of Finance/CFO 49 08-05-31
Chief Tech/Sci/R&D Officer - 16-12-31
Members of the board TitleAgeSince
Director/Board Member 63 16-11-08
Chairman 63 04-02-29
Director/Board Member 65 07-01-28
More insiders
Date Price Change Volume
24-03-18 5.39 +0.37% 532,799
24-03-15 5.37 -0.74% 684,511
24-03-14 5.41 -2.70% 423,515
24-03-13 5.56 +1.28% 300,370
24-03-12 5.49 +0.37% 385,671

Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT

More quotes
AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. It is engaged in manufacturing, developing, and selling medical devices for vascular access, peripheral vascular disease, and oncology on a global basis. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, midlines, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and 400 Micron Perforator & Accessory Vein Ablation Kit (PVAK). Its vascular interventions include Syntrax Support Catheter, AlphaVac, SpeedLyser PRO Infusion System. Its ports include Xcela Plus Ports and Conventional Ports.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.39 USD
Average target price
14 USD
Spread / Average Target
+159.74%
Consensus
  1. Stock
  2. Equities
  3. Stock AngioDynamics, Inc. - Nasdaq